Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned
Código 3006 (Harmonized System 2012 by 4 digits)
2023: US$502M, Total Trade Exchange
2023: US$155M, International Sales
2023: US$347M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned was US$502M.
In 2023, the states with the most international sales in Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned were Ciudad de México (US$60M), Chihuahua (US$23.9M), Baja California (US$22.7M), Jalisco (US$17.4M), and Sonora (US$14.8M).
The states with the most international purchases in 2023 were Ciudad de México (US$244M), Tamaulipas (US$33.6M), Baja California (US$22.1M), Chihuahua (US$17.8M), and Jalisco (US$13.1M).
In 2023, the main commercial destinations of Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned were United States (US$89.5M), Argentina (US$17.3M), Brazil (US$10.9M), Colombia (US$7.55M), and Panama (US$6.45M).
The main commercial origins of Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned in 2023 were United States (US$96.6M), Finland (US$61.5M), Germany (US$55M), Netherlands (US$21.8M), and Ireland (US$21M).
In the global context, the main exporting countries of Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned in 2022 were Germany (US$3.31B), United States (US$2.16B), and Netherlands (US$1.47B). In the same year, the main importing countries of Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned were United States (US$3.74B), Germany (US$1.34B), and Belgium (US$1.14B).
Trade Balance of Mexico
#permalink to sectionNet Trade Balance
#permalink to sectionUS$502M, Total Trade Exchange (2023)
In 2023, the total trade exchange of Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned in Mexico (including international purchases and sales) was US$502M.
The visualizations show the net balance of Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
Net International Trade
#permalink to sectionNovember, 2024
- US$29.4M, International Purchases
- US$11M, International Sales
In November 2024, international sales of Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned were US$11M, while international purchases reached US$29.4M. The above results in a trade balance of -US$18.3M.
Market Concentration
#permalink to section2024-Q4: US$19.8M, International Sales
The visualization shows the quarterly concentration of international sales of Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned at state level.
In the fourth quarter of 2024, international sales were US$19.8M, being the states with the most sales Chihuahua (US$5.92M), Ciudad de México (US$3.22M), and Baja California (US$3.09M).
Exchange by Territory
#permalink to sectionInternational Sales
#permalink to sectionCiudad de México: US$60M, State with the Most International Sales (2023)
United States: US$89.5M, Main commercial destination (2023)
In 2023, the states with the highest international sales in Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned were Ciudad de México (US$60M), Chihuahua (US$23.9M), Baja California (US$22.7M), Jalisco (US$17.4M), and Sonora (US$14.8M).
In 2023, the countries with the most international purchases from Mexico were United States (US$89.5M), Argentina (US$17.3M), Brazil (US$10.9M), Colombia (US$7.55M), and Panama (US$6.45M).
International Purchases
#permalink to sectionCiudad de México: US$244M, State with the Most International Purchases (2023)
United States: US$96.6M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned were Ciudad de México (US$244M), Tamaulipas (US$33.6M), Baja California (US$22.1M), Chihuahua (US$17.8M), and Jalisco (US$13.1M).
The countries with the most international sales to Mexico in 2023 were United States (US$96.6M), Finland (US$61.5M), Germany (US$55M), Netherlands (US$21.8M), and Ireland (US$21M).
Specialization
#permalink to sectionSpecialization by State
#permalink to sectionThe RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
Global Market
#permalink to sectionOrigins and Trade Destinations
#permalink to section- 2.56%, Mexican share in global exports - 2022
- 1.25%, Mexican share in global imports - 2022
The visualizations show the global market for Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned were Germany (US$3.31B), United States (US$2.16B), and Netherlands (US$1.47B). In the same year, the main importing countries for Pharmaceutical Goods Specified in Note 4 of this Chapter is Concerned were United States (US$3.74B), Germany (US$1.34B), and Belgium (US$1.14B).